Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 32.0032
- Book/Share 7.0534
- PB 5.6404
- Debt/Equity 2.1543
- CurrentRatio 2.7621
- ROIC 0.0735
- MktCap 1612604916.0
- FreeCF/Share 1.0328
- PFCF 38.5505
- PE 33.3867
- Debt/Assets 0.4522
- DivYield 0.0121
- ROE 0.1826
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Read More
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Published: September 02, 2025 by: Seeking Alpha
Sentiment: Positive
Phibro Animal Health Corporation's Zoetis MFA acquisition has revitalized its overall growth. Animal Health is now around 75% of their total sales, and its integration should be finalized by Q4 2025. Post-integration, PAHC believes Zoetis MFAs will normalize to flat growth. But, Vaccines and Nutritional Specialties should continue growing at double digits. PAHC's Phibro Forward initiative is also adding new efficiencies in procurement, commercial, and process improvements.
Read More
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript
Published: August 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.
Read More
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Best Growth Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Read More
Best Value Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Read More
Best Growth Stocks to Buy for July 17th
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Positive
QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 17, 2025.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Best Growth Stocks to Buy for July 10th
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
GOOS, PAHC and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 10, 2025.
Read More
Invest in 4 Winning Stocks With Proven Relative Price Power
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
DELL, JBL, PAHC, and HBM are showing strong relative price strength and upward earnings estimates amid a rising market.
Read More
Best Growth Stocks to Buy for July 8th
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive
STRT, PAHC and AFYA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 8, 2025.
Read More
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost
Published: July 07, 2025 by: Benzinga
Sentiment: Positive
JPMorgan upgraded Phibro Animal Health Corporation PAHC, citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.
Read More
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue?
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Phibro Animal Health Stock Up 52.8% in a Year: What's Driving the Rise?
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC stock is under investors' radar due to its booming animal health sales, new product lines and rising vaccine demand.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Reasons to Add PAHC Stock to Your Portfolio Right Now
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro's strong Animal Health momentum and global expansion bode well for investors.
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like BPOP, AMG, ATRO and PAHC are seeing price strength and have a high chance of carrying the momentum forward.
Read More
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Read More
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940